Single-Cell Detection of Secreted Aβ and sAPPα from Human IPSC-Derived Neurons and Astrocytes.
- Authors
- Liao, Mei-Chen; Muratore, Christina R; Gierahn, Todd M; Sullivan, Sarah E; Srikanth, Priya; De Jager, Philip L; Love, J Christopher; Young-Pearse, Tracy L
- Year
- 2016
- Journal
- The Journal of neuroscience : the official journal of the Society for Neuroscience
- PMID
- 26843653
- DOI
- 10.1523/JNEUROSCI.2735-15.2016
- PMCID
- PMC4737781
UNLABELLED: Secreted factors play a central role in normal and pathological processes in every tissue in the body. The brain is composed of a highly complex milieu of different cell types and few methods exist that can identify which individual cells in a complex mixture are secreting specific analytes. By identifying which cells are responsible, we can better understand neural physiology and pathophysiology, more readily identify the underlying pathways responsible for analyte production, and ultimately use this information to guide the development of novel therapeutic strategies that target the cell types of relevance. We present here a method for detecting analytes secreted from single human induced pluripotent stem cell (iPSC)-derived neural cells and have applied the method to measure amyloid β (Aβ) and soluble amyloid precursor protein-alpha (sAPPα), analytes central to Alzheimer's disease pathogenesis. Through these studies, we have uncovered the dynamic range of secretion profiles of these analytes from single iPSC-derived neuronal and glial cells and have molecularly characterized subpopulations of these cells through immunostaining and gene expression analyses. In examining Aβ and sAPPα secretion from single cells, we were able to identify previously unappreciated complexities in the biology of APP cleavage that could not otherwise have been found by studying averaged responses over pools of cells. This technique can be readily adapted to the detection of other analytes secreted by neural cells, which would have the potential to open new perspectives into human CNS development and dysfunction. SIGNIFICANCE STATEMENT: We have established a technology that, for the first time, detects secreted analytes from single human neurons and astrocytes. We examine secretion of the Alzheimer's disease-relevant factors amyloid β (Aβ) and soluble amyloid precursor protein-alpha (sAPPα) and present novel findings that could not have been observed without a single-cell analytical platform. First, we identify a previously unappreciated subpopulation that secretes high levels of Aβ in the absence of detectable sAPPα. Further, we show that multiple cell types secrete high levels of Aβ and sAPPα, but cells expressing GABAergic neuronal markers are overrepresented. Finally, we show that astrocytes are competent to secrete high levels of Aβ and therefore may be a significant contributor to Aβ accumulation in the brain.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | 2018 | 29897633 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Altered Amyloid-β42 and BACE-1 Proteins in Plasma Astrocyte-Derived Exosomes in Hypertensive Patients With Cerebral Microbleeds. | Liu X et al. | — | 2026 | → |
| Neuronal subtype governs amyloid structure, cellular response, and cognitive outcome in genetically targeted APP mouse models. | Perez GA et al. | — | 2026 | → |
| Profiling signaling mediators for cell-cell interactions and communications with microfluidics-based single-cell analysis tools. | Yuan S et al. | — | 2025 | → |
| Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier. | Takeuchi LE et al. | — | 2025 | → |
| Amyloid precursor protein induces reactive astrogliosis. | Velezmoro Jauregui G et al. | — | 2024 | → |
| Astrocytes: The Stars in Neurodegeneration? | Stoklund Dittlau K et al. | — | 2024 | → |
| In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline. | Pereira MF et al. | — | 2024 | → |
| Recording γ-secretase activity in living mouse brains | Hou SS et al. | — | 2024 | — |
| Recording γ-secretase activity in living mouse brains. | Hou SS et al. | — | 2024 | → |
| Single cell glucose-stimulated insulin secretion assay using nanowell-in-microwell plates. | Jang D et al. | — | 2024 | → |
| 3D bioengineered neural tissue generated from patient-derived iPSCs mimics time-dependent phenotypes and transcriptional features of Alzheimer's disease. | Lomoio S et al. | — | 2023 | → |
| Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells? | Rodriguez-Jimenez FJ et al. | — | 2023 | → |
| Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. | Brandebura AN et al. | — | 2023 | → |
| Goat <i>CLSTN2</i> gene: tissue expression profile, genetic variation, and its associations with litter size. | Wijayanti D et al. | — | 2023 | → |
| hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer's disease and potential therapeutics. | Tcw J et al. | — | 2023 | → |
| Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology. | Cai W et al. | — | 2023 | → |
| Alzheimer's Disease: Treatment Strategies and Their Limitations. | Passeri E et al. | — | 2022 | → |
| In-Depth Characterization of Endo-Lysosomal Aβ in Intact Neurons. | McKendell AK et al. | — | 2022 | → |
| Mapping secretome-mediated interaction between paired neuron-macrophage single cells. | Deng J et al. | — | 2022 | → |
| Unraveling the Mechanobiology Underlying Traumatic Brain Injury with Advanced Technologies and Biomaterials. | Shao X et al. | — | 2022 | → |
| ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer's Disease. | Patro S et al. | — | 2021 | → |
| Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models. | Cenini G et al. | — | 2021 | → |
| Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases. | Trudler D et al. | — | 2021 | → |
| Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration. | Lazar E et al. | — | 2021 | → |
| Mechanical Stress Induces a Transient Suppression of Cytokine Secretion in Astrocytes Assessed at the Single-Cell Level with a High-Throughput Microfluidic Chip. | Shao X et al. | — | 2021 | → |
| Primary Cilia in Glial Cells: An Oasis in the Journey to Overcoming Neurodegenerative Diseases. | Ki SM et al. | — | 2021 | → |
| Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons. | Satir TM et al. | — | 2020 | → |
| A Three-Dimensional Alzheimer's Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1. | Hernández-Sapiéns MA et al. | — | 2020 | → |
| Contribution of GABAergic interneurons to amyloid-β plaque pathology in an APP knock-in mouse model. | Rice HC et al. | — | 2020 | → |
| Disease-associated astrocytes in Alzheimer's disease and aging. | Habib N et al. | — | 2020 | → |
| Identification of Molecular Signatures in Neural Differentiation and Neurological Diseases Using Digital Color-Coded Molecular Barcoding. | Salerno D et al. | — | 2020 | → |
| Microfluidic Single-Cell Omics Analysis. | Xu X et al. | — | 2020 | → |
| Modeling Alzheimer's disease with iPSC-derived brain cells. | Penney J et al. | — | 2020 | → |
| Monolithic hydrogel nanowells-in-microwells enabling simultaneous single cell secretion and phenotype analysis. | Choi JR et al. | — | 2020 | → |
| Pluripotent stem cells for neurodegenerative disease modeling: an expert view on their value to drug discovery. | Chen SD et al. | — | 2020 | → |
| Proteomic examination of the neuroglial secretome: lessons for the clinic. | Kim JH et al. | — | 2020 | → |
| The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling. | Lee C et al. | — | 2020 | → |
| Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo. | Liang Y et al. | — | 2020 | → |
| When glia meet induced pluripotent stem cells (iPSCs). | Li L et al. | — | 2020 | → |
| Alzheimer's in a dish - induced pluripotent stem cell-based disease modeling. | de Leeuw S et al. | — | 2019 | → |
| Chemical Analysis of Single Cells. | Oomen PE et al. | — | 2019 | → |
| Fluorescence-Activated Cell Sorting and NanoString Profiling of Single Neural Crest Cells and Pigment Cells. | Subkhankulova T et al. | — | 2019 | → |
| Important advances in Alzheimer's disease from the use of induced pluripotent stem cells. | Majolo F et al. | — | 2019 | → |
| Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer's Disease. | Atkinson-Dell R et al. | — | 2019 | → |
| Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease. | Wu YY et al. | — | 2019 | → |
| Physiological effects of amyloid precursor protein and its derivatives on neural stem cell biology and signaling pathways involved. | Coronel R et al. | — | 2019 | → |
| Pluripotent Stem Cells for Brain Repair: Protocols and Preclinical Applications in Cortical and Hippocampal Pathologies. | Alia C et al. | — | 2019 | → |
| Pushing the limits of detection for proteins secreted from single cells using quantum dots. | Herrera V et al. | — | 2019 | → |
| Single-Cell Protein Secretion Detection and Profiling. | Chen Z et al. | — | 2019 | → |
| The Use of Pluripotent Stem Cell-Derived Organoids to Study Extracellular Matrix Development during Neural Degeneration. | Yan Y et al. | — | 2019 | → |
| Altered Expression of Urea Cycle Enzymes in Amyloid-β Protein Precursor Overexpressing PC12 Cells and in Sporadic Alzheimer's Disease Brain. | Jęśko H et al. | — | 2018 | → |
| A stocked toolbox for understanding the role of astrocytes in disease. | Almad A et al. | — | 2018 | → |
| Characterization of Tissue Plasminogen Activator Expression and Trafficking in the Adult Murine Brain. | Stevenson TK et al. | — | 2018 | → |
| Dissecting human disease with single-cell omics: application in model systems and in the clinic. | Strzelecka PM et al. | — | 2018 | → |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | — | 2018 | → |
| Modeling neurological diseases using iPSC-derived neural cells : iPSC modeling of neurological diseases. | Li L et al. | — | 2018 | → |
| Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells. | Rowland HA et al. | — | 2018 | → |
| Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease. | Ceyzériat K et al. | — | 2018 | → |
| Transient increase in sAPPα secretion in response to Aβ1-42 oligomers: an attempt of neuronal self-defense? | Rose C et al. | — | 2018 | → |
| Aberrant iPSC-derived human astrocytes in Alzheimer's disease. | Jones VC et al. | — | 2017 | → |
| A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants. | Ryan KJ et al. | — | 2017 | → |
| Amyloid-beta neurotoxicity and clearance are both regulated by glial group II metabotropic glutamate receptors. | Durand D et al. | — | 2017 | → |
| APP as a Protective Factor in Acute Neuronal Insults. | Hefter D et al. | — | 2017 | → |
| Astrocytes in a dish: Using pluripotent stem cells to model neurodegenerative and neurodevelopmental disorders. | Crompton LA et al. | — | 2017 | → |
| Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability. | Muratore CR et al. | — | 2017 | → |
| Induced pluripotent stem cell technology: a decade of progress. | Shi Y et al. | — | 2017 | → |
| PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease. | Oksanen M et al. | — | 2017 | → |
| Scaling by shrinking: empowering single-cell 'omics' with microfluidic devices. | Prakadan SM et al. | — | 2017 | → |
| Stem cell models of Alzheimer's disease: progress and challenges. | Arber C et al. | — | 2017 | → |
| 3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish". | Choi SH et al. | — | 2016 | → |
| Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease. | Goetzl EJ et al. | — | 2016 | → |
| Gene Expression Analysis of Neurons and Astrocytes Isolated by Laser Capture Microdissection from Frozen Human Brain Tissues. | Tagliafierro L et al. | — | 2016 | → |
| Gold Nanoparticles in Single-Cell Analysis for Surface Enhanced Raman Scattering. | Altunbek M et al. | — | 2016 | → |
| Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system. | Dá Mesquita S et al. | — | 2016 | → |
| Macrophage secretion heterogeneity in engineered microenvironments revealed using a microwell platform. | McWhorter FY et al. | — | 2016 | → |